Neuberger Berman Group LLC Dr Reddys Laboratories LTD Transaction History

Neuberger Berman Group LLC

  • $121 Billion
  • Q4 2024

A detailed history of Neuberger Berman Group LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Neuberger Berman Group LLC holds 72,999 shares of RDY stock, worth $992,786. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,999
Previous 14,923 389.17%
Holding current value
$992,786
Previous $1.19 Million 2.78%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$13.99 - $79.75 $812,483 - $4.63 Million
58,076 Added 389.17%
72,999 $1.15 Million
Q3 2024

Nov 14, 2024
BUY
$75.41 - $84.21 $321,849 - $359,408
4,268 Added 40.06%
14,923 $1.19 Million
Q2 2024

Nov 14, 2024
SELL
$68.26 - $76.19 $3.96 Million - $4.42 Million
-58,069 Reduced 84.5%
10,655 $811,000
Q2 2024

Aug 13, 2024
SELL
$68.26 - $76.19 $3.96 Million - $4.42 Million
-58,069 Reduced 84.5%
10,655 $811,000
Q1 2024

Nov 14, 2024
SELL
$67.36 - $77.59 $1.83 Million - $2.1 Million
-27,126 Reduced 28.3%
68,724 $5.04 Million
Q1 2024

May 13, 2024
BUY
$67.36 - $77.59 $4.63 Million - $5.33 Million
68,724 New
68,724 $5.04 Million
Q4 2023

Nov 14, 2024
BUY
$64.27 - $69.9 $5.48 Million - $5.96 Million
85,195 Added 799.58%
95,850 $6.67 Million
Q4 2023

Feb 09, 2024
BUY
$64.27 - $69.9 $1.25 Million - $1.36 Million
19,497 Added 25.54%
95,850 $6.67 Million
Q3 2023

Nov 14, 2023
BUY
$61.9 - $72.77 $4.06 Million - $4.77 Million
65,517 Added 604.62%
76,353 $5.11 Million
Q2 2023

Aug 11, 2023
SELL
$53.34 - $63.11 $1.31 Million - $1.55 Million
-24,551 Reduced 69.38%
10,836 $683,000
Q1 2023

May 12, 2023
BUY
$51.63 - $56.93 $1.83 Million - $2.01 Million
35,387 New
35,387 $2.01 Million
Q2 2022

Aug 15, 2022
BUY
$49.62 - $58.13 $475,806 - $557,408
9,589 New
9,589 $531,000
Q4 2021

Feb 11, 2022
SELL
$59.5 - $67.25 $4.41 Million - $4.99 Million
-74,157 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$60.19 - $75.29 $3.39 Million - $4.24 Million
-56,292 Reduced 43.15%
74,157 $4.81 Million
Q2 2021

Aug 13, 2021
SELL
$62.12 - $74.2 $668,162 - $798,095
-10,756 Reduced 7.62%
130,449 $9.54 Million
Q1 2021

May 13, 2021
BUY
$57.98 - $73.08 $502,222 - $633,018
8,662 Added 6.54%
141,205 $8.67 Million
Q4 2020

Feb 10, 2021
BUY
$62.61 - $71.29 $5.84 Million - $6.64 Million
93,205 Added 236.93%
132,543 $9.44 Million
Q3 2020

Nov 12, 2020
BUY
$51.39 - $72.41 $1.52 Million - $2.14 Million
29,530 Added 301.08%
39,338 $2.74 Million
Q2 2020

Aug 13, 2020
BUY
$39.55 - $54.65 $387,906 - $536,007
9,808 New
9,808 $520,000
Q1 2018

May 08, 2018
SELL
$31.93 - $39.54 $249,469 - $308,926
-7,813 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$34.15 - $37.62 $266,813 - $293,925
7,813
7,813 $293,000

Others Institutions Holding RDY

# of Institutions
263
Shares Held
93.1M
Call Options Held
58.1K
Put Options Held
17K
View Full List

About DR REDDYS LABORATORIES LTD

RDY Quotes by TradingView
  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.26B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email